The SARS-CoV-2 lambda variant (lineage C. 37) was designated by the World Health
Organization as a variant of interest and is currently increasing in prevalence in South …

Severe acute respiratory syndrome coronavirus 2 variants have continued to emerge in
diverse geographic locations with a temporal distribution. The Lambda variant containing …

A recently identified SARS-CoV-2 variant, Lambda, has spread to many countries around
the world. Here, we measured and evaluated the reduced sensitivity of Lambda variant to …

Background The newly described SARS-CoV-2 lineage C. 37 was recently classified as a
variant of interest by the WHO (Lambda variant) based on its high circulation rates in South …

The spike protein of SARS-CoV-2 is the target of antibodies in convalescent and vaccine
sera, and 23 mutations in spike protein were reported in the variants B. 1.1. 7, B. 1.351, and …

Summary SARS-CoV-2 Lambda, a variant of interest, has spread in some South American
countries; however, its virological features and evolutionary traits remain unclear. In this …

Highly efficacious vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) have been developed. However, the emergence of viral variants that are more …

The omicron variant of SARS-CoV-2 infected very large numbers of SARS-CoV-2 vaccinated
and convalescent individuals–. The penetrance of this variant in the antigen experienced …

The SARS-CoV-2 B. 1.621 (Mu) variant emerged in January 2021 and was categorized as a
variant of interest by the World Health Organization in August 2021. This designation …

Background Highly efficacious vaccines against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have been developed. However, the emergence of viral …